Антифосфолипидный синдром - Насонов Е.Л.
ISBN 5-98216-010-5
Скачать (прямая ссылка):
28. Tanne D, Hassin-Baer S. Neurologic manifestations of the antiphospholipid syndrome. Curr Rheumatol Report 2001; 3: 286—292.
29. Shah NM, Khamashta MA, Atsumi T, Hughes GRV. Outcome of patients with anticardiolipin antibodies: a 10years follow-up of 52 patients. Lupus 1998; 7:3—6.
30. Hilker R, Thiel A, Geisen C, Rudolf J. Cerebral blood flow and glucose metabolism in multi-infarct-dementia related to primary antiphospholipid antibody syndrome. Lupus 2000; 9: 311—6.
31. Khamashta MA, Gil A, Anciones B et al. Chorea in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis 1988; 47: 681—3.
32. Asherson RA, Derksen RH, Harris EN et al. Chorea in systemic lupus erythematosus and lupus-like'disease: association with antiphospho-lipid antibodies. Semin Arthritis Rheum 1987; 16: 253—9.
33. Asherson RA, Khamashta MA, Gil A et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphos-pholipid syndrome. Amer J Med 1989; 86: 391—9.
34. Kushner M, Simonian N. Lupus anticoagulants, anticardiolipin antibodies, and cerebral ishemia. Stroke 1989; 20: 225—229.
35. Levine SR, Salowich-Palm L, Sawaya KL et al. IgG anticardiolipin antibody titer >40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study. Stroke 1997; 28: 1660—5.
36. Levine SR, Deegan MJ, Futrell N, Welch KM. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990; 40: 1181—1189.
37. Provenzale JM, Barboriak DP, Allen NB, Ortel TL. Patients with antiphospholipid antibod-
SHS-OOO4.qxd 21.11.2006 16:56 Page 196
Насонов Е.Л. Антифосфолипидный синдром.
ies: CT and MR findings of the brain. Am J Roentgenol 1996; 67: 1573—1578.
38. Khamashta MA, Cervera R, Asherson RA et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythe-matosus. Lancet 1990; 335:1541—4.
39. Nesher G, Ilany J, Rosenmann D, Abraham AS. Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment. Semin Arthritis Rheum 1997; 27: 27—35.
40. Erkan D, Roman MJ, Tenedios F, Lockshin MD. Cardiac involvement in the antiphospholipid syndrome. In. The Heart in Systemic Autoimmune Disease. Ed. A. Doria, P. Pauletto. Elseiver, Amsterdam, Boston, Heidelberg 2004; 213—225.
41. Cuadrado MJ, Khamashta MA, Ballesteros A, Godfrey T, Simon MJ, Hughes GRV. Can neurologic manifestations of Hughes (antiphos-pholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore) 2000; 79: 57— 68.
42. Mackworth-Young CG, Hughes GRV. Epilepsy: an early symptom of systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 1985; 48:185.
43. Inzelberg R, Korczyn AD. Lupus anticoagulant and the late onset seizures. Acta Neurol Scand 1989; 79: 114—118.
44. Herranz MT, Rivier G, Khamashta MA, Blaser KU, Hughes GRV. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum 1994; 37: 568—571.
45. Liou HH, Wang CR, Chen CJ et al. Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients. Lupus 1996; 5: 307— 12.
46. Verrot D, San-Marco M, Dravet C et al. Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy. Amer J Med 1997; 103: 33—37.
47. Peltola JT, Haapala A, Isojarvi JI et al. Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders. Amer J Med 2000; 109: 712—717.
48. Levine SR, Joseph R, G DA, Welch KM. Migraine and the lupus anticoagulant. Case
reports and review of the literature. Cephalalgia 1987; 7: 93—9.
49. Hogan MJ, Brunet DG, Ford PM, Lillicrap D. Lupus anticoagulant, antiphospholipid antibodies and migraine. Can J Neurol Sci 1988; 15: 420—5.
50. Tzourio C, Kittner SJ, Bousser MG, Alperovitch A. Migraine and stroke in young women. Cephalalgia 2000; 20: 190—199.
51. Shuaib A, Barklay L, Lee MA, Suchowersky O. Migraine and anti-phospholipid antibodies. Headache 1989; 29: 42—45.
52. Montalban J, Cervera R, Font J et al. Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus. Neurology 1992; 42: 681—682.
53. Tietjen GE. Migraine and antiphospholipid antibodies. Cephalalgia 1992; 12: 69—74.
54. Sanna G, Cuadrado MJ, Nurchis P, Kha-mashta MA, Mathieu A, Hughes GRV. Prevalence of headache and relationship with the presence of antiphospholipid antibodies in patients with systemic lupus erythematosus. J Autoimmun 2000; 15: P177 (A75).
55. Hanly JG, Walsh NM, Fisk JD et al. Cognitive impairment and autoantibodies in systemic lupus erythematosus. Br J Rheumatol 1993; 32: 291—296.
56. Denburg SD, Carbotte RM, Ginsberg JS, Denburg JA. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J Int Neuropsychol Soc 1997; 3: 377—386.
